233 related articles for article (PubMed ID: 30615112)
1. Data-driven discovery and validation of circulating blood-based biomarkers associated with prevalent atrial fibrillation.
Chua W; Purmah Y; Cardoso VR; Gkoutos GV; Tull SP; Neculau G; Thomas MR; Kotecha D; Lip GYH; Kirchhof P; Fabritz L
Eur Heart J; 2019 Apr; 40(16):1268-1276. PubMed ID: 30615112
[TBL] [Abstract][Full Text] [Related]
2. Quantification of fibroblast growth factor 23 and N-terminal pro-B-type natriuretic peptide to identify patients with atrial fibrillation using a high-throughput platform: A validation study.
Chua W; Law JP; Cardoso VR; Purmah Y; Neculau G; Jawad-Ul-Qamar M; Russell K; Turner A; Tull SP; Nehaj F; Brady P; Kastner P; Ziegler A; Gkoutos GV; Pavlovic D; Ferro CJ; Kirchhof P; Fabritz L
PLoS Med; 2021 Feb; 18(2):e1003405. PubMed ID: 33534825
[TBL] [Abstract][Full Text] [Related]
3. B-type natriuretic peptide for incident atrial fibrillation-The Heinz Nixdorf Recall Study.
Kara K; Geisel MH; Möhlenkamp S; Lehmann N; Kälsch H; Bauer M; Neumann T; Dragano N; Moebus S; Jöckel KH; Erbel R; Mahabadi AA
J Cardiol; 2015 Jun; 65(6):453-8. PubMed ID: 25241013
[TBL] [Abstract][Full Text] [Related]
4. Brain natriuretic peptide: a relevant marker to rule out delayed atrial fibrillation in stroke patient.
Suissa L; Bresch S; Lachaud S; Mahagne MH
J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):e103-10. PubMed ID: 23010631
[TBL] [Abstract][Full Text] [Related]
5. Pre-ablation levels of brain natriuretic peptide are independently associated with the recurrence of atrial fibrillation after radiofrequency catheter ablation in patients with nonvalvular atrial fibrillation.
Miake J; Kato M; Ogura K; Iitsuka K; Okamura A; Tomomori T; Tsujimoto D; Kato M; Yamamoto K
Heart Vessels; 2019 Mar; 34(3):517-526. PubMed ID: 30238353
[TBL] [Abstract][Full Text] [Related]
6. Circulating fibroblast growth factor-23 and the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities study.
Alonso A; Misialek JR; Eckfeldt JH; Selvin E; Coresh J; Chen LY; Soliman EZ; Agarwal SK; Lutsey PL
J Am Heart Assoc; 2014 Sep; 3(5):e001082. PubMed ID: 25237047
[TBL] [Abstract][Full Text] [Related]
7. Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community.
Schnabel RB; Larson MG; Yamamoto JF; Sullivan LM; Pencina MJ; Meigs JB; Tofler GH; Selhub J; Jacques PF; Wolf PA; Magnani JW; Ellinor PT; Wang TJ; Levy D; Vasan RS; Benjamin EJ
Circulation; 2010 Jan; 121(2):200-7. PubMed ID: 20048208
[TBL] [Abstract][Full Text] [Related]
8. Impact of B-type natriuretic peptide level on the risk of left atrial appendage thrombus in patients with nonvalvular atrial fibrillation: a prospective study.
Pant R; Patel M; Garcia-Sayan E; Wassouf M; D'Silva O; Kehoe RF; Doukky R
Cardiovasc Ultrasound; 2016 Jan; 14():4. PubMed ID: 26772738
[TBL] [Abstract][Full Text] [Related]
9. B-type natriuretic peptide, disease progression and clinical outcomes in atrial fibrillation.
Inohara T; Kim S; Pieper K; Blanco RG; Allen LA; Fonarow GC; Gersh BJ; Ezekowitz MD; Kowey PR; Reiffel JA; Naccarelli GV; Chan PS; Mahaffey KW; Singer DE; Freeman JV; Steinberg BA; Peterson ED; Piccini JP;
Heart; 2019 Mar; 105(5):370-377. PubMed ID: 30228248
[TBL] [Abstract][Full Text] [Related]
10. Role of NT-proANP and NT-proBNP in patients with atrial fibrillation: Association with atrial fibrillation progression phenotypes.
Büttner P; Schumacher K; Dinov B; Zeynalova S; Sommer P; Bollmann A; Husser D; Hindricks G; Kornej J
Heart Rhythm; 2018 Aug; 15(8):1132-1137. PubMed ID: 29604419
[TBL] [Abstract][Full Text] [Related]
11. Relation between soluble ST2, growth differentiation factor-15, and high-sensitivity troponin I and incident atrial fibrillation.
Rienstra M; Yin X; Larson MG; Fontes JD; Magnani JW; McManus DD; McCabe EL; Coglianese EE; Amponsah M; Ho JE; Januzzi JL; Wollert KC; Fradley MG; Vasan RS; Ellinor PT; Wang TJ; Benjamin EJ
Am Heart J; 2014 Jan; 167(1):109-115.e2. PubMed ID: 24332149
[TBL] [Abstract][Full Text] [Related]
12. Addition of B-Type Natriuretic Peptide to Existing Clinical Risk Scores Enhances Identification of Patients at Risk for Atrial Fibrillation Recurrence After Pulmonary Vein Isolation.
Shaikh AY; Esa N; Martin-Doyle W; Kinno M; Nieto I; Floyd KC; Browning C; Ennis C; Donahue JK; Rosenthal LS; McManus DD
Crit Pathw Cardiol; 2015 Dec; 14(4):157-65. PubMed ID: 26569657
[TBL] [Abstract][Full Text] [Related]
13. Elevated plasma norepinephrine level and sick sinus syndrome in patients with lone atrial fibrillation.
Yoshida K; Kaneshiro T; Ito Y; Kimata A; Koda N; Hiraya D; Baba M; Misaki M; Takeyasu N; Yamaguchi I; Aonuma K
Heart; 2015 Jul; 101(14):1133-8. PubMed ID: 25968056
[TBL] [Abstract][Full Text] [Related]
14. B-type natriuretic peptide predicts left atrial appendage thrombus in patients with nonvalvular atrial fibrillation.
Doukky R; Gage H; Nagarajan V; Demopoulos A; Cena M; Garcia-Sayan E; Karam GJ; Kazlauskaite R
Echocardiography; 2013 Sep; 30(8):889-95. PubMed ID: 23496263
[TBL] [Abstract][Full Text] [Related]
15. Exploring the incremental utility of circulating biomarkers for robust risk prediction of incident atrial fibrillation in European cohorts using regressions and modern machine learning methods.
Toprak B; Brandt S; Brederecke J; Gianfagna F; Vishram-Nielsen JKK; Ojeda FM; Costanzo S; Börschel CS; Söderberg S; Katsoularis I; Camen S; Vartiainen E; Donati MB; Kontto J; Bobak M; Mathiesen EB; Linneberg A; Koenig W; Løchen ML; Di Castelnuovo A; Blankenberg S; de Gaetano G; Kuulasmaa K; Salomaa V; Iacoviello L; Niiranen T; Zeller T; Schnabel RB
Europace; 2023 Mar; 25(3):812-819. PubMed ID: 36610061
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of N-terminal pro-B-type natriuretic Peptide levels for stroke risk prediction in anticoagulated patients with atrial fibrillation.
Roldán V; Vílchez JA; Manzano-Fernández S; Jover E; Gálvez J; Puche CM; Valdés M; Vicente V; Lip GY; Marín F
Stroke; 2014 Mar; 45(3):696-701. PubMed ID: 24519407
[TBL] [Abstract][Full Text] [Related]
17. Brain Natriuretic Peptide Is a Powerful Predictor of Outcome in Stroke Patients with Atrial Fibrillation
.
Maruyama K; Uchiyama S; Shiga T; Iijima M; Ishizuka K; Hoshino T; Kitagawa K
Cerebrovasc Dis Extra; 2017; 7(1):35-43. PubMed ID: 28253498
[TBL] [Abstract][Full Text] [Related]
18. Elevated admission N-terminal pro-brain natriuretic peptide level predicts the development of atrial fibrillation in general surgical intensive care unit patients.
Chokengarmwong N; Yeh DD; Chang Y; Ortiz LA; Kaafarani HMA; Fagenholz P; King DR; DeMoya M; Butler K; Lee J; Velmahos G; Januzzi JL; Lee-Lewandrowski E; Lewandrowski K
J Trauma Acute Care Surg; 2017 Sep; 83(3):485-490. PubMed ID: 28463935
[TBL] [Abstract][Full Text] [Related]
19. Predictive Markers of Atrial Fibrillation in Patients with Transient Ischemic Attack.
Pedersen KB; Madsen C; Sandgaard NCF; Diederichsen ACP; Bak S; Nybo M; Brandes A
J Stroke Cerebrovasc Dis; 2020 Apr; 29(4):104643. PubMed ID: 32005569
[TBL] [Abstract][Full Text] [Related]
20. Ability of B-type natriuretic peptide in predicting postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting.
Ata Y; Turk T; Ay D; Eris C; Demir M; Ari H; Ata F; Yavuz S; Ozyazicioglu A
Heart Surg Forum; 2009 Aug; 12(4):E211-6. PubMed ID: 19683991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
